Steward Partners Investment Advisory, LLC Pro Qr Therapeutics N.V. Transaction History
Steward Partners Investment Advisory, LLC
- $11 Billion
- Q4 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Pro Qr Therapeutics N.V. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 651 shares of PRQR stock, worth $1,367. This represents 0.0% of its overall portfolio holdings.
Number of Shares
651Holding current value
$1,367% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRQR
# of Institutions
63Shares Held
18.6MCall Options Held
37.7KPut Options Held
21.3K-
Privium Fund Management B.V.4.99MShares$10.5 Million3.12% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$7.61 Million0.01% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA1.84MShares$3.86 Million0.14% of portfolio
-
Platinum Investment Management LTD Sydney Australia 2000, C31.54MShares$3.23 Million0.25% of portfolio
-
M28 Capital Management LP Stamford, CT1.02MShares$2.14 Million1.76% of portfolio
About ProQR Therapeutics N.V.
- Ticker PRQR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,362,096
- Market Cap $150M
- Description
- ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...